Large mortgage companies are targeting mergers and acquisitions as well as home equity lending in their 2025 business plans, ...

Similar to Bacillus Calmette-Guérin (BCG) therapy used for bladder cancer, ICVB-1042 is designed to train the immune system on tumors but with a cancer-specific response and a robust immune reaction.

Good morning. Women executives who reach the top in finance are reshaping the profession while creating newfound value for their companies, according to Boston Consulting Group (BCG).

A new report released today, January 22, from Nasdaq and Boston Consulting Group (BCG), suggests that by embracing a systems-based approach powered by modern technologies like artificial ...

QTI Fibers, a Norwest Equity Partners portfolio company, has appointed Abhi Agrawal as CEO. The company said this strategic ...

Detalimogene voraplasmid, enGene's lead asset, shows high complete response rates in BCG-unresponsive NMIBC patients, positioning it as a viable monotherapy option. Financials reveal a market cap ...

Baltic Classifieds Group PLC (LON:BCG – Get Free Report) insider Edmund Williams bought 9,139 shares of the company’s stock in a transaction that occurred on Wednesday, March 12th. The stock was ...

Supply shortages of TICE BCG in the U.S. have become a significant impediment to the treatment of bladder cancer patients. In a recent Sermo survey of 100 U.S. urologists, 57 percent indicated ...

ImmunityBio (IBRX) announced U.S. Urology Partners, one of the nation’s largest independent providers of urology and related specialty ...